Skip to main content

Lia Garcia Gilabert

I am a predoctoral student in the research group of Childhood Cancer and Hematologic Diseases at Vall d'Hebron Research Institute (VHIR).

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Lia Garcia Gilabert

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

I am a predoctoral student in the research group of Childhood Cancer and Hematologic Diseases at Vall d'Hebron Research Institute (VHIR).

I studied Biomedicine at the University of Barcelona (2017-2021). During the degree I did an extracurricular internship in the Neurochemistry group at the Department of Biomedicine of the Faculty of Medicine and Health Sciences of the University of Barcelona (2019). In this stay I collaborated in the characterization of the phagocytic capacity of the brain microglia by using cell cultures and immunocytochemical stainings. During my undergraduate studies, I was also instructor of the Human Physiology II practices from the Biomedicine degree. There I collaborated with the teaching of the laboratory practices, with the preparation of reagents and with the handling of basic physiology equipment. Afterwards, I completed the official Master in Translational Biomedical Research at the Vall d'Hebron Research Institute (VHIR) (2021-2022). I carried out my final degree and master's thesis in the group of Monitoring and modulation of brain circuits in brain diseases, at the Department of Biomedicine of the Faculty of Medicine and Health Sciences of the University of Barcelona. The research I performed during this time consisted mainly in the study and modulation of certain neuronal circuits using optogenetics and DREADDs (Designer Receptors Activated by Designer Drugs) in an animal model of Huntington's disease. This stay in the lab has allowed me to become second author of several posters presented at scientific congresses. Currently, I have started working as a predoctoral student in the research group of Childhood Cancer and Hematological Diseases at Vall d'Hebron Research Institute (VHIR).

Projects

Desarrollo de una nueva plataforma preclínica para evaluar y optimizar tratamientos de mantenimiento en el sarcoma de Ewing

IP: Josep Roma Castanyer
Collaborators: Raquel Hladun Alvaro, Júlia Sansa Girona, Lia Garcia Gilabert, Patricia Zarzosa Martinez, Lucas Moreno Martín-Retortillo
Funding agency: Fundación Aless Lequio
Funding: 50000
Reference: ALESSLEQUIO/PROJECTE/2025/ROMA
Duration: 01/01/2026 - 31/12/2027

Desarrollo avanzado de terapias innovadoras contra los sarcomas infantiles: refinamiento del bloqueo farmacológico de los co-receptores de la Vía Hedgehog

IP: Josep Roma Castanyer
Collaborators: Guillem Pons Barcons, Raquel Hladun Alvaro, Júlia Sansa Girona, Lia Garcia Gilabert, Gabriela Guillén Burrieza, Patricia Zarzosa Martinez
Funding agency: Instituto de Salud Carlos III
Funding: 190000
Reference: PI24/00825
Duration: 01/01/2025 - 31/12/2027

Development of a novel and potent strategy for blocking the Hedgehog pathway to treat pediatric sarcomas

IP: Josep Roma Castanyer
Collaborators: Guillem Pons Barcons, Raquel Hladun Alvaro, Júlia Sansa Girona, Lia Garcia Gilabert, Patricia Zarzosa Martinez, Lucas Moreno Martín-Retortillo
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 20000
Reference: 2024 LLAV 00024
Duration: 02/12/2024 - 01/06/2025

Liquid biopsy in paediatric sarcomas: deciphering the predictive potential of circulating tumour DNA and tumour-derived exosomes for early relapse detection

IP: Josep Roma Castanyer
Collaborators: Lia Garcia Gilabert
Funding agency: Fundació La Marató de TV3
Funding: 170000
Reference: 20193730
Duration: 29/10/2020 - 31/12/2023

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Vall d'Hebron is one of the centers that coordinate this network, which so far has enabled the detection of high-risk genetic alterations and the provision of personalized treatments that have already achieved remission in cases with very few therapeutic alternatives.

The projects, selected under the 2026 Health Research and CaixaImpulse Health Innovation calls, address topics ranging from new therapies for childhood neurological disorders and Parkinson’s disease to the treatment of mitochondrial diseases and cancer.

Related professionals

Isis Aguilera González

Isis Aguilera González

Research assistant
Transfusional Medicine
Read more
Fernando Lozano Palacio

Fernando Lozano Palacio

Postdoctoral researcher
Biomedical Research in Urology
Read more
Sergio López Soto

Sergio López Soto

Research technician
Childhood Cancer and Blood Disorders
Read more
María Escribano Cebrián

María Escribano Cebrián

Predoctoral researcher
Head and Neck Cancer: Biomedical Research Cancer Stem cells
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.